DOSTINEX
DOSTINEX
Approved
DIN Number
02242471
Drug Class
Human
Market Date
Jun 30, 2000
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02242471
AIG Number0141281001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G02CB03 CABERGOLINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:36.20.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
CABERGOLINEActive
Strength: 0.5 MG
Monograph: CABERGOLINE